Advertisement

Topics

Latest "Indiana Blood and Marrow Transplantation" News Stories

02:08 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "Indiana Blood and Marrow Transplantation" found in our extensive news archives from over 250 global news sources.

More Information about Indiana Blood and Marrow Transplantation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Indiana Blood and Marrow Transplantation for you to read. Along with our medical data and news we also list Indiana Blood and Marrow Transplantation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Indiana Blood and Marrow Transplantation Companies for you to search.

Showing "Indiana Blood Marrow Transplantation" News Articles 1–25 of 6,000+

Friday 19th October 2018

Shanghai RAAS Blood Products Co Ltd 002252 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryShanghai RAAS Blood Products Co Ltd Shanghai RAAS is a biotechnology company that researches, develops, manufactures and distributes blood products plasma derived medicinal products. The company's products include human serum albumin, intravenous human immunoglobulin, other blood products, Chinese medicine products and other products. Its products focus on hematology, immunology and intensi...


New Fly Species May Indicate Changing Climate

News A new type of blow fly points to shifting species populations due to climate change. Contributed Author: 

Phone app connects CPR-certified locals to nearby cardiac arrests

Officials in Clark County, Indiana, are urging locals to download a new phone app that would alert CPR-certified individuals to cardiac arrests happening nearby. An accompanying app also maps out the county’s nearest automated external defibrillators.


FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Two Rare Forms of Vasculitis

Rituxan label updated to include information for follow up treatment in adult patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) who have achieved disease control with induction treatment Rituxan in combination with glucocorticoids (GCC) is the only FDA-approved therapy for these rare, po...

Transcranial sonography predicts functional outcome after stroke thrombectomy

Transcranial duplex sonography (TCD) can assess middle cerebral artery blood flow and provide prognostic information for stroke patients after thrombectomy for large vessel occlusions, suggests a report published Oct. 15 in Stroke.

Terumo BCT Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryTerumo BCT Inc Terumo BCT, a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis and cellular technologies. The company's product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell separation system, pathogen reduction technology system, whole blood processing system, orbisac system, ...

Renal replacement therapy: summary of NICE guidance

What you need to knowStart exploring the options of dialysis, transplantation, or conservative management with patients at least a year before they are likely to need itRecommend patients start...

Novartis to acquire Indiana-based Endocyte for $2.1B

Novartis, a large healthcare company based in Basel, Switzerland, has agreed to acquire Endocyte, a West Lafayette, Indiana-based biopharmaceutical company, for $2.1 billion.

apceth Biopharma Presents Positive Data Demonstrating Efficacy of apceth-201 in Preclinial Models of Acute GvHD

Munich, Germany, October 19, 2018 / B3C newswire / -- apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies, announced today positive results for apceth-201 in mouse models for acute graft-versus-host disease (aGvHD). The data was highlighted in a poster presentation at the Annual Congress of the European Society of Gene and Cell Ther...

$GH Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients #ESMO18 https://www.prnewswire.com/news-releases/guardant-health-presents-data-on-immunotherapy-related-biomarkers-msi-and-tmb-in-blood-of-advanced-canc

$GH Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients #ESMO18 https://www.prnewswire.com/news-releases/guardant-health-presents-data-on-immunotherapy-related-biomarkers-msi-and-tmb-in-blood-of-advanced-cancer-patients-at-european-society-of-medical-oncology-annua

Cancer Treatment Can Often Come Too Late, But What If You Could Get Ahead Of The Disease?

A new study, called Project Baseline, is trying to pinpoint the transition from normal health to disease. Researchers hope that the project could lead to the identification of new markers in the blood, stool or urine of healthy people that help predict cancer, cardiovascular disease and other leading killers of Americans. In other news, why don't all cancer-linked mutations in cells turn into tumo...

Sandoz International GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummarySandoz International GmbH Sandoz, a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio products. Sandoz offers products for oncology, central nervous system CNS, respiratory, pain and ophth...

Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress

Product innovations with recent approvals across Baxter’s Acute Therapies, Clinical Nutrition and Medication Delivery businesses to be featured Two Baxter-sponsored symposia with key opinion leaders to focus on helping to prevent medication errors as well as innovations in continuous renal replacement therapy and sepsis ma...

Hydroxycloroquine Blood Concentration in Lupus Nephritis

Abnormally low hydroxychloroquine blood levels may suggest non-adherence and predict poor outcomes in lupus nephritis. Nephrology Dialysis Transplantation

Blood Pressure Targets for Patients With HTN and CVD

Do lower BP targets help or hurt patients with HTN and a history of CVD? American Family Physician

Voters Likely To Pick And Choose Among Device Industry Favorites In Close Races

Among the very tight Republican and Democrat contests anticipated in this November’s US midterm elections are more than a few...    

New Fly Species Found in Indiana may Indicate Changing Climate

NewsA new type of blow fly spotted in Indiana points to shifting species populations due to climate change. Contributed Author: 

Liver Transplant Rejection Pipeline Review, H2 2018 [Report Updated: 11092018] Prices from USD $2000

Liver Transplant Rejection Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection Pipeline Review, H2 2018, provides an overview of the Liver Transplant Rejection Immunology pipeline landscape.Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability to rege...

TextMail, an Automatic, Customizable Text Message Reply App, Officially Launches in Google Play

TextMail lets users send hands-free text replies customized to their current unavailability. INDIANAPOLIS (PRWEB) October 19, 2018 TextMail, a customizable autoreply text app by Galvan Technologies LLC, has officially launched in the Google Play store. It offers three different modes to automatically reply to incoming text messages - Auto-Reply, Driver, and Out of the Office. It is a useful app f...

Rocket Pharmaceuticals Presents Preclinical Data at the 2018 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)

- Promising Preclinical Results from Leukocyte Adhesion Deficiency-I and Infantile Malignant Osteopetrosis Programs – - Leukocyte Adhesion Deficiency-I Program On Track to Enter Clinic in 2019; Infantile Malignant Osteopetrosis Program in 2020- Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-plat...

Exact Sciences acquires Biomatrica

Exact Sciences has paid an undisclosed amount for San Diego-based Biomatrica, which makes blood and saliva collection tubes a -More- 

Clovis Oncology Presents Initial Results from the Ongoing Rubraca® (rucaparib) TRITON Program in Metastatic Castration Resistant Prostate Cancer (mCRPC) at ESMO 2018 Congress

44% confirmed objective response rate (ORR) reported in 25 RECIST-evaluable patients with a BRCA1/2 alteration in initial data from ongoing TRITON2 Phase 2 study; median duration of response has not yet been reached 51% confirmed PSA response rate shown in 45 PSA-evaluable patients with a BRCA1/2 alteration ...

GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at the European Society for Medical Oncology (ESMO) 2018 Congress

GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced that new data from the Circulating Cell-free Genome Atlas (CCGA) study will be presented by Minetta Liu, MD, Research Chair and Professor, Department of Oncology, Mayo Clinic, in an oral presentation at the European Society for Medical Oncology (ESMO) 2018 Congress ...

Medical News Today: Why does diabetes cause fatigue?

It is common for people with diabetes to experience fatigue. Causes can include high blood sugar levels, depression, being overweight, and other related health conditions. Controlling blood sugar levels and lifestyle changes can help a person reduce fatigue. Learn more here.

Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study

SAN DIEGO and SHANGHAI, Oct. 19, 2018 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, a UC San Diego spinout company focused on non-invasive early cancer detection, today announce initial results from the Taizhou Longitudinal Study (TLS) during the 2018 American Society of Human Genetics (ASHG) Annual Meeting.  An oral pre...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks